6640--CTX Immunoassay Random Access Multiplex Analyzer
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25726Q0240 in this department, oldest first.
- Feb 2, 2026 · this noticeCombined Synopsis/Solicitation
- Feb 18, 2026Award NoticeGOVERNMENT SCIENTIFIC SOURCE INC · $271KOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 17, is issuing a solicitation for the procurement of a commercial, fully automated, random access multiplex immunoassay analyzer system for the Central Texas Veterans Health Care System (CTVHCS), Temple, Texas. This acquisition is being conducted on an unrestricted basis using the revised FAR commercial products and commercial services procedures (FAR Part 12 as updated by the FAR Revolutionary Overhaul) and will result in a single firm fixed price contract. The requirement is to replace an existing end of life immunoass… (show all)
ay analyzer supporting the Pathology & Laboratory Medicine Service. The new system shall be a commercial, fully automated, random access multiplex immunoassay analyzer capable of performing autoimmune, infectious disease, and specialty immunoassay testing on a consolidated platform. At a minimum, the system shall: (1) provide programmable STAT/priority testing; (2) accept CLSI standard specimen tubes; (3) operate on standard 110 volt power; (4) include an appropriate uninterruptible power supply (UPS); (5) provide integrated quality control capabilities; and (6) include delivery, installation, initial operational verification, and removal of the existing analyzer at CTVHCS Temple. The Government anticipates using a Lowest Price Technically Acceptable (LPTA) best value approach under FAR Part 12 and the updated FAR Part 15. Technical acceptability will be evaluated on a pass/fail basis against clearly defined minimum requirements set forth in the solicitation; among offers determined technically acceptable, award is expected to be made to the responsible offeror with the lowest total evaluated price, subject to a determination of price reasonableness. The applicable NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. This procurement is posted as UNRESTRICTED; all responsible sources may submit an offer. Offerors must be registered in the System for Award Management (SAM) under the applicable NAICS code prior to award. The solicitation and any amendments will be issued electronically via the Contract Opportunities portal on SAM.gov. No paper copies of the solicitation will be provided. It is the responsibility of interested parties to monitor SAM.gov for the posting of the solicitation, any amendments, and all other related information.
Who won similar work
10 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) 6640 and NAICS 334516.
Single-winner award sizes (8): middle half $221K to $1.2M, median $314K; range $40K to $1.6M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ABBOTT LABORATORIES INC. · $ABT · $45.1B | 2 | $1.9M | Jun 24, 2025 |
| BECKMAN COULTER, INC | 2 | $1.3M | Jan 28, 2026 |
| BECTON, DICKINSON AND COMPANY · $BDX · $22.5B | 1 | $1.3M | Aug 2, 2025 |
| CEPHEID SUNNYVALE 94089 | 1 | $333K | May 15, 2026 |
| AGILENT TECHNOLOGIES, INC. · $A · $7.4B | 1 | $295K | Jul 14, 2026 |
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 1 | $40K | Jan 28, 2025 |
| ORTHO-CLINICAL DIAGNOSTICS, INC · $QDEL · $2.7B | 1 | – + 1 shared | May 20, 2025 |
| WERFEN USA LLC | 1 | – + 1 shared | May 15, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $ABT reported $45.1B revenue (12 months to Mar 31, 2026). The median single-winner award in these 8 past awards, $314K, is under 0.1% of that. SEC filing
- $BDX reported $22.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 8 past awards, $314K, is under 0.1% of that. SEC filing
- $A reported $7.4B revenue (12 months to Jul 31, 2026). The median single-winner award in these 8 past awards, $314K, is under 0.1% of that. SEC filing
- $QDEL reported $2.7B revenue (12 months to Jun 28, 2026). The median single-winner award in these 8 past awards, $314K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Jul 14, 2026AGILENT TECHNOLOGIES, INC.$295K6640--NEW - Seahorse XF Pro Analyzer - Laboratory InstrumentationMateriality: <0.01% of $A revenue (Low) SEC
- May 15, 2026CEPHEID SUNNYVALE 94089$333K6640--Molecular Diagnostic SystemNo listed company matched (Materiality N/A)
- Jan 28, 2026BECKMAN COULTER, INC$1.1M6640--NEW - Automated Hematology CPRR and InstrumentationNo listed company matched (Materiality N/A)
- Sep 16, 2025BECKMAN COULTER, INC$171K6640--STVHCS Microscan MALDI Cost Per TestNo listed company matched (Materiality N/A)
- Aug 2, 2025BECTON, DICKINSON AND COMPANY$1.3M6640--CTX Microbiology Automation SystemMateriality: <0.01% of $BDX revenue (Low) SEC
- Jun 24, 2025ABBOTT LABORATORIES INC.$1.6M6640--Immunoassay CPRR (HIV, HEP, Tacrolimus)Materiality: <0.01% of $ABT revenue (Low) SEC
- May 20, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$334K (shared ceiling)6640--STVHCS - Automated Blood Bank Analyzer - Cost Per TestShared multiple-award ceiling, not one company's win (Materiality N/A)
- May 15, 2025WERFEN USA LLC$334K (shared ceiling)6640--STVHCS - Automated Blood Bank Analyzer - Cost Per TestShared multiple-award ceiling, not one company's win (Materiality N/A)
- Feb 24, 2025ABBOTT LABORATORIES INC.$238K6640--NEW - VCB Automation Line Bridge 3mo+3moMateriality: <0.01% of $ABT revenue (Low) SEC
- Jan 28, 2025POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$40K6640--El Paso Lab OC-Sensor Diana Analyzer - PolymedcoNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (5 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $72K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 4 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.